IVIG is a purified plasma product, primarily containing immunoglobulin G (IgG) antibodies, which is administered intravenously. In the context of neonatal jaundice, IVIG is used specifically as an adjunct therapy to phototherapy, particularly for cases caused by severe isoimmune hemolytic disease of the newborn (HDN), such as ABO or Rh incompatibility. Its mechanism of action in this ... https://www.databridgemarketresearch.com/reports/global-neonatal-jaundice-intravenous-immunoglobulin-market